Back
Lifevantage 10K Form
Buy
64
LFVN
Lifevantage
Last Price:
$13.03
Seasonality Move:
19.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | LFVN/Lifevantage Quarterly |
2024-01-30 | 10Q | LFVN/Lifevantage Quarterly |
2023-11-09 | 10Q | LFVN/Lifevantage Quarterly |
2023-05-04 | 10Q | LFVN/Lifevantage Quarterly |
2023-02-02 | 10Q | LFVN/Lifevantage Quarterly |
2022-11-02 | 10Q | LFVN/Lifevantage Quarterly |
Receive LFVN News And Ratings
See the #1 stock for the next 7 days that we like better than LFVN
LFVN Financial Statistics
Sales & Book Value
Annual Sales: | $200.2M |
---|---|
Cash Flow: | $1.9M |
Price / Cash Flow: | 15.39 |
Annual Sales: | $2.70 |
Price / Book: | 5.23 |
Profitability
EPS (TTM): | 0.69000 |
---|---|
Net Income (TTM): | $9.2M |
Gross Margin: | $158.7M |
Return on Equity: | 31.7% |
Return on Assets: | 13.92% |
Lifevantage Earnings Forecast
Key Lifevantage Financial Ratios
-
The Gross Profit Margin over the past 26 years for LFVN is 79.30%.
-
The Selling, General & Administrative Expenses for LFVN have been equal to 34.21% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.32% of Operating Income.
-
The Net Earning history of LFVN is 1.47% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 12 years.
Lifevantage Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Personal Care Products |
Sector: | Consumer Staples |
Current Symbol: | LFVN |
CUSIP: | 53222K |
Website: | lifevantage.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.66 |
Quick Ratio: | 0.79 |
Price-to-Earnings
Trailing P/E Ratio: | 61.39 |
---|---|
Forward P/E Ratio: | 10.62 |
LFVN Technical Analysis vs Fundamental Analysis
Buy
64
Lifevantage (LFVN)
is a Buy
Is Lifevantage a Buy or a Sell?
-
Lifevantage stock is rated a BuyThe current Lifevantage [LFVN] share price is $14.12. The Score for LFVN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.